Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy.

about

Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy.

Item

http://www.wikidata.org/entity/Q50697654

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Survival and prognostic factor ...... and carboplatin chemotherapy.

@en

Survival and prognostic factor ...... and carboplatin chemotherapy.

@nl

type

Item

label

Survival and prognostic factor ...... and carboplatin chemotherapy.

@en

Survival and prognostic factor ...... and carboplatin chemotherapy.

@nl

prefLabel

Survival and prognostic factor ...... and carboplatin chemotherapy.

@en

Survival and prognostic factor ...... and carboplatin chemotherapy.

@nl

P1476

Survival and prognostic factor ...... l and carboplatin chemotherapy

@en

P2093

Chumnan Kietpeerakool

http://www.w3.org/2001/XMLSchema#string

Jatupol Srisomboon

http://www.w3.org/2001/XMLSchema#string

Narisa Sribanditmongkol

http://www.w3.org/2001/XMLSchema#string

Supareuk Phongsaranantakul

http://www.w3.org/2001/XMLSchema#string

Surapan Khunamornpong

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer.

Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.

Primary fallopian tube carcinoma: the Queensland experience.

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.

Fallopian tube malignancies: A retrospective clinical pathological study of 17 cases.

Primary fallopian tube carcinoma - the experience of a UK cancer centre and a review of the literature.

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors.

Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.

Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.

P304

806-811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOG.12241

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chalong Cheewakriangkrai

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24738123

http://www.w3.org/2001/XMLSchema#string

P921

fallopian tube